ERBB2 and ovarian carcinoma: In particular, it has been proposed that apoptosis induction is broadly mediated by caspase-3 pathway activation, which has been established by increased sensitivity to paclitaxel using adenoviral type 5 E1A in human HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 cells.